Volatility & Outlook

Volatility remains a factor: the stock has experienced 12 price moves exceeding 5 % in the past year, yet the recent 3.5 % afternoon surge is attributed more to analyst sentiment than a fundamental shift. Analyst optimism, driven by stronger June transaction trends, suggests that employer demand for fertility and family‑building benefits will continue to support earnings growth, even amid cost pressures and competition. Projections for 2029 require significant yearly revenue growth, and some forecasts posit only 6.3 % annual revenue growth, underscoring the need for investors to assess the risk‑reward balance carefully. The fair‑value estimate of $29.73 represents an 8 % downside to the current price, though momentum and earnings‑estimate revisions remain positive.